Coronary artery bypass graft surgery. Atherosclerosis of coronary artery bypass graft(s), unspecified, with unspecified angina pectoris
Conditions
Interventions
Intervention 1: Intervention group 1: Intravenous infusion of midazolam (manufactured by Oxir Pharmaceutical Co.) 0.15 mg/kg single dose before anesthesia. Intervention 2: Intervention group 2: Intra
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
40 Years to 70 Years
Inclusion criteria
Inclusion criteria: Age of 40 to 70 years, Candidate for coronary artery bypass graft surgery,
Exclusion criteria
Exclusion criteria: Diabetes, Requires emergency coronary artery bypass graft surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate. Timepoint: One minute before induction of anesthesia and at 1, 2, 5 and 10 minutes after intubation. Method of measurement: Using monitoring machine.;Systolic blood pressure. Timepoint: One minute before induction of anesthesia and at 1, 2, 5 and 10 minutes after intubation. Method of measurement: Using monitoring machine.;Mean arterial blood pressure. Timepoint: One minute before induction of anesthesia and at 1, 2, 5 and 10 minutes after intubation. Method of measurement: Using monitoring machine.;Electrocardiographic changes. Timepoint: One minute before induction of anesthesia and at 1, 2, 5 and 10 minutes after intubation. Method of measurement: Using monitoring machine.;Diastolic blood pressure. Timepoint: One minute before induction of anesthesia and at 1, 2, 5 and 10 minutes after intubation. Method of measurement: Using monitoring machine. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParsa Afghanian
Hamedan University of Medical Sciences
Outcome results
None listed